about
Epidemiology of Japanese encephalitis in the Philippines: a systematic reviewBurden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature reviewCholera in India: an analysis of reports, 1997-2006Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India.The global burden of cholera.Epidemiology of cholera in the PhilippinesRisk map of cholera infection for vaccine deployment: the eastern Kolkata case.Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings.Trials and tribulations of conducting interventional studies in urban slums of a developing country: Experiences from Kolkata, India.Cholera vaccines for the developing world.Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008.Rubella and Congenital Rubella Syndrome in the Philippines: A Systematic Review.Surveillance for tuberculosis in a rural community in The Philippines.Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.Assessing different measures of population-level vaccine protection using a case-control study.Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand.An overview of the status of acellular pertussis vaccines in practice.Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure.Correction: Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case.The burden of congenital rubella syndrome in the Philippines: results from a retrospective assessment.Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?Cholera prevention and control in Asian countriesCorrection: Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited SettingsIntroduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practicesEffect of heat inactivation of serum on Bordetella pertussis antibody determination by enzyme-linked immunosorbent assayRanitidine and late-onset sepsis in the neonatal intensive care unitOral cholera vaccines--a call for actionImmune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trialHepatitis B seroprevalence among 5 to 6 years old children in the Philippines born prior to routine hepatitis B vaccination at birthProspects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policyUrine Xpert MTB/RIF for the diagnosis of childhood tuberculosis
P50
Q27304581-13AAF159-E828-433A-9889-5ACF63A0F836Q28742681-CF0CB930-EA0B-4140-8273-FB98B03F31A1Q33689166-3AD664FE-CEF0-48C5-98D1-632B4B4B1C41Q33808779-BBE530F3-9FDB-4822-B3C5-7F6CF54D97A1Q34092762-6DC69F55-41C2-4D16-A223-9A680B0F53E9Q34637074-75458948-06AD-4D40-B3B7-8C3F910C0858Q34875516-911A556F-96AE-47AB-92A2-A49D55D2D902Q34926521-72137451-C05B-46C4-AA03-C2B48376775AQ35091828-3D62C12E-7CC5-4C85-91CE-1BB823A1D978Q35170821-B37FBA1E-D5F7-4148-820B-5B5180FBDF02Q35886885-82074296-E911-4F75-BE4B-64518000F53FQ37130173-9464E918-08E4-4C63-8202-3B6ED3207E8EQ37138956-9B4E1409-0DA1-4A7B-9EFC-92B5850DF9A7Q37191671-289FD5AD-3AD3-42A4-9D87-52F31A94939CQ37578596-84344E9F-6595-4BA9-91A0-366CCA30430BQ39189004-36DE8DD5-3B0B-4106-A873-8AD03DC761B6Q40088781-F1EB2F6C-1EC4-42C5-8571-F5A1BEFE9930Q40168559-220DF32F-62E5-4852-B092-13BEB332B6D2Q40545451-B4E617CE-AECA-4896-B749-1F88110A0ACAQ40661355-DC0C3687-3291-4CCC-94B5-2C632111A77EQ41563023-554C91C9-DF8D-43A6-BFA6-E5DCD052C69DQ44302592-8A3DB5E7-4DE1-45F5-A02D-8EADF5987837Q46030208-319C58DB-9FBA-42E9-B777-74F25BCA643CQ46715360-4270BE4C-6F22-4907-8742-1134A59502B7Q47581091-9A499676-51C0-4433-846F-26008D5F4531Q59790372-F8F843BE-5ED8-4799-8E0D-9AE46DE97ECCQ60551606-0419883D-F738-4472-9B79-FCB6879C968CQ64135932-611B484E-0274-4DBE-8434-21D2F98636C3Q74264050-5DE05FFE-EAC1-4EFC-8224-C1D87AC2028CQ79779460-A38D67C2-2E6C-4103-9EE3-BD9C4C8B5D02Q82958075-60422630-D6EF-443F-9B0B-A30F54937702Q84569360-399EC18F-7829-4381-8FF4-568AA6D3476DQ88933792-9255AD3B-0E04-4602-BBA6-F301749C7B61Q90249148-3D5CBE94-B7EA-4D8C-B96F-56A22E8A0A5FQ93369505-4CA87C05-95C8-42E2-9EFF-BDEC7D130BAC
P50
description
researcher
@en
name
A L Lopez
@en
A L Lopez
@nl
type
label
A L Lopez
@en
A L Lopez
@nl
prefLabel
A L Lopez
@en
A L Lopez
@nl
P106
P31
P496
0000-0003-0013-620X